ENTPD1 and melanoma: The relative abundance of these cells among CD39+PD-1+ Tex cells in the tumor and stroma area (excluding TLS areas) showed no clear impact on clinical outcomes (Fig. S1F), which is consistent with previous melanoma findings21.